PeptideStack
5.2kquestions
20kanswers
220users

Is 40 mg in 2 mL of 0.9% sodium chloride a sensible presentation for cagrilintide?

Asked 17 Aug 2024Modified 19 months agoViewed 48k times
This question was closed as primarily opinion-based.Closed 28 Sept 2024. Answers already posted are preserved; new answers are not accepted. Questions here need a factual basis on which they can be answered.
38

Concretely: 40 mg · 2 mL · 0.9% sodium chloride · cagrilintide.

I want to decide this in advance so that I am not deciding it under pressure later.

Assume I will follow the plan I write down, so I would like it to be a good one.

How would you structure this, and what thresholds would you set in advance?

diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

295 questions
reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

313 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
amylin
amylin

Amylin and its analogues, most prominently cagrilintide, as a satiety mechanism orthogonal to incretin signalling. Includes the pharmacology of…

237 questions
shareeditfollowflag
ET
askedellis_thorne17k1717 Aug 2024

3 Answers

Accepted answer first, then by votes
81

Accepted answer

It gives 20 mg/mL, and whether that is sensible depends on the dose you will draw from it. 40 ÷ 2 = 20 mg/mL in 0.9% sodium chloride. A 0.5 mg dose is then 2.5 units on a U-100 barrel and a 1 mg dose is 5 units. The smaller dose lands too low on the scale to read accurately — more diluent would buy resolution you cannot recover later.

Aim for a dose volume somewhere between about 10 and 30 units on a U-100 barrel and the reading problem disappears.

The other direction: 10 mg in 3 mL is 3.33 mg/mL, and a 0.5 mg dose becomes 0.15 mL, or 15 units. More barrel, easier reading, and a larger fraction of the vial volume lost to dead space across the same number of draws.

Concentration and unit conversion at a glance

VialDiluentConcentration0.25 mg0.5 mg1 mg2.5 mg
5 mg1 mL5 mg/mL5 u10 u20 u50 u
5 mg2 mL2.5 mg/mL10 u20 u40 u100 u
10 mg1 mL10 mg/mL2.5 u5 u10 u25 u
10 mg2 mL5 mg/mL5 u10 u20 u50 u
10 mg3 mL3.33 mg/mL7.5 u15 u30 u75 u

Units are U-100 insulin units, where 1 unit = 0.01 mL. Divide dose by concentration for millilitres, then multiply by 100.

Dead-space loss scales with the number of draws, not with the concentration, so a lower concentration spread over more draws loses proportionally less of the total peptide.

Insulin syringe barrel graduations are typically 1 unit on a 0.3 mL barrel, 1 unit on a 0.5 mL barrel and 2 units on a 1 mL barrel, which is why the barrel size changes what is readable.

A concentration calculated to three decimal places from a diluent volume measured to one is false precision.

Write the concentration on the label at reconstitution, in units per dose.

edited 17 Dec 2024 by bac_or_bust — fixed an arithmetic slip in the third paragraph

shareimprove this answerflag
BB
answered · acceptedbac_or_bust33k1372 Dec 2024
8Minor: the filter membrane chemistry matters as much as the pore size for adsorption. – Dr_Ravi_Selvarajah 4 months ago
7Adding that a fixed-needle syringe loses about a tenth of what a luer one does. – ivo_paunovic 3 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
30

Answering this needs the syringe you actually own, because the barrel graduations decide what "readable" means.

Vial headspace is the hard constraint. A nominal 2 mL vial typically holds a little over 2 mL to the shoulder; adding 3 mL is not an option and attempting it wastes the lot.

For a dose that will change during titration, choose the volume for the largest intended dose rather than the first, so the whole schedule fits on one barrel without a mid-vial recalculation.

Nominal vial volumes in the standard 2R and 3R glass sizes have published brimful capacities well above the nominal fill, but the usable volume is bounded by the stopper displacement.

Do not change the diluent volume between vials of a titration without recalculating; it is the commonest source of a ten-fold error.

Check the vial can physically hold the volume before you draw it up.

shareimprove this answerflag
TO
answeredt_oyelaran79k4813 Dec 2024
Would this be different for a peptide that foams? Mine does and I have never known why. – Dr_Idris_Coulibaly 7 months ago
add a comment
22

Answer first: diluent volume sets concentration and therefore resolution on the syringe barrel, and resolution is free at reconstitution and impossible to recover afterwards.

Content matters. If the same 10 mg vial assays at 94 per cent content, you have 9.4 mg. In 2 mL that is 4.7 mg/mL, and a nominal 0.5 mg draw of 10 units actually delivers 0.47 mg — a six per cent shortfall that no amount of careful drawing will fix.

Write the concentration and the resulting units-per-dose on the vial label at reconstitution. The arithmetic that is obvious now will not be obvious at six in the morning three weeks from now.

U-100 means 100 units per millilitre by definition, so 1 unit is 0.01 mL and volume in millilitres times one hundred gives units. Every conversion here reduces to that.

Nothing here is medical advice, and research-use material is not approved for human use.

Choose the volume that puts your largest intended dose between 10 and 30 units. Everything else follows.

shareimprove this answerflag
PT
answeredpascal_thibault11k179 Nov 2024

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.